Dane Andreeff - 12 Sep 2022 Form 4 Insider Report for HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)

Role: President and CEO, Director, 10%+ Owner
Signature: /s/ Dane Andreeff
Issuer symbol: HSDT
Transactions as of: 12 Sep 2022
Net transactions value: +$85,033
Form type: 4
Filing time: 14 Sep 2022, 16:38:29 UTC
Previous filing: 26 Aug 2022
Next filing: 18 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HSDT	Common Stock	Purchase	$2,587	+4,752	+3.4%	$0.5444	144,819	12 Sep 2022	See footnote	F1
transaction	HSDT	Common Stock	Purchase	$552	+1,014	+3.3%	$0.5444	31,645	12 Sep 2022	See footnote	F2
transaction	HSDT	Common Stock	Purchase	$1,545	+2,838	+3.3%	$0.5444	88,618	12 Sep 2022	See footnote	F3
transaction	HSDT	Common Stock	Purchase	$144	+264	+3.5%	$0.5444	7,881	12 Sep 2022	See footnote	F4
transaction	HSDT	Common Stock	Purchase	$80,205	+150,000	+169%	$0.5347	238,618	13 Sep 2022	See footnote	F3
holding	HSDT	Common Stock						1,508	12 Sep 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HSDT	Stock Option (Right to Buy)	Award	$0	+86,000		$0.000000	86,000	13 Sep 2022	Common Stock	86,000	$0.5400	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F2	The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I and as such may be deemed to beneficially own the securities owned by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F3	The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities owned by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F4	The shares are held by Maple Leaf Offshore Ltd. ("MLO"). The reporting person is the president of the managing member of Andreeff Equity Advisors, L.L.C., the investment manager of MLO and as such may be deemed to beneficially own the securities owned by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F5	Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. The options vest in a series of twelve (12) successive equal quarterly installments on the last day of each quarter so that all of the options will be vested on the three-year anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting period.